RE:RE:RE:RE:What price could Theralase fetch ? IMHO, a BTD at this point in time after 63 patients pretty much guarantees an eventual FDA approval. Basically it would be like FDA saying you will get approval just complete the trial or apply for AA once you complete enrolment of patients.
Kayz88 wrote: Absolutely agreed. BTD wouldn't be a savior nor would it hold any water in the long term for this stock. However, it WILL vindicate a lot of the posters here as well as the company to be given a BTD. For longevity it will need further approvals for marketability.
However, with BTD, it will grant a window of breathing space:
- A small/medium/large pop in stock price to fill up the coffers if timed/executed correctly
- Possible exercise of warrants which will further the battle chest
- Recognition in the cancer fighting space, it's no longer a theory but starting to materialize as a viable option via this BTD
- Slightly more freedom in funding further indications
But the BTD needs to be followed up with more confirmation from the governing bodies to keep the stock price going.